Cyclosporine

Therapeutic drug monitoring of cyclosporine is performed to support immunosuppressant therapy management in transplant patients, and UTAK offers quality control materials containing cyclosporine within our immunosuppressant product offerings to help laboratories validate assay performance and ensure accurate, reproducible results. Stock controls such as Immunosuppressants Level 1–3 are formulated in human whole blood with defined concentrations of cyclosporine and related calcineurin inhibitors including everolimus, sirolimus, and tacrolimus to support a range of clinical testing platforms. Custom immunosuppressant QC solutions can be tailored to meet your laboratory’s specific therapeutic drug monitoring needs and concentration requirements.